Genentech
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Genentech
Oct 8, 2024, 15:11 |
Blog
Ashley Magargee: My 20th anniversary at Genentech
Ashley Magargee shared on LinkedIn: "Last month officially marked my 20th anniversary at Genentech! I…
Oct 2, 2024, 14:06 |
Blog
Aakash Desai: Excited for the IMPACT-NSCLC study presented at ASCO Quality Care Symposium
Aakash Desai, Assistant Professor, UAB O'Neal Comprehensive Cancer Center, shared a post by Shashi Shankar,…
Sep 26, 2024, 13:58 |
Blog
Renjith Vijayakumar Selvarani: A Turning Point for Cancer Vaccines
Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post…
Sep 14, 2024, 10:15 |
Career
Melinda Aldrich has been appointed to the ASHG Board of Directors
Melinda Aldrich was recently elected to the (American Society of Human Genetics) ASHG Board of…
Aug 11, 2024, 21:32 |
Blog
Full power of innovation to achieve the goals of The White House Cancer Moonshot initiative - Genomate Health
Genomate Health posted on LinkedIn: "As a CancerX Moonshot founding member, we collaborate with other…
Aug 11, 2024, 19:26 |
Blog
Know Your Biomarkers: The 'Ask About ALK' Campaign
ALK Positive Inc. posted on LinkedIn: "Sponsored by Genentech. When Nikki was diagnosed with lung…
Aug 8, 2024, 11:55 |
Blog
Why it’s important to talk to a healthcare provider about biomarker testing - ALK Positive Inc.
ALK Positive Inc. shared a post on LinkedIn: ''Sponsored by Genentech. For Mike, finding out…
Jul 24, 2024, 14:01 |
Blog
Eleni Taoula: Complex global regulatory landscape for ADCs
Eleni Taoula, Associate Professor at The University of Nicosia Medical School, shared on LinkedIn: "ADC drugs…
Jul 22, 2024, 16:46 |
Insight
Friends HRD Harmonization Project with Patsy Hinson - Friends of Cancer Research
Friends of Cancer Research shared on X: "It is very important for patients to have…
Jul 2, 2024, 10:32 |
Insight
Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA
MedEdge MEA shared a post on LinkedIn: . "A year of treatment with a medicine…
Jun 29, 2024, 15:03 |
Insight
IO inductive therapy let 25% unresectable stage 3 NSCLC become resectable
Thomas Wu, Research physician at Genentech, shared a post by X: "Our paper just out…
Jun 9, 2024, 08:07 |
Blog
Ashley Magargee: I am so proud that Genentech is part of the Biden Cancer Moonshot program
Ashley Magargee, Chief Executive Officer at Genentech, shared a post by Genentech on LinkedIn: "We…
May 23, 2024, 20:08 |
Blog
Maria Babak: Join the UNITY Summit organized by The University of Illinois Cancer Center and don't forget about the OncoParty2024
Maria Babak shared a post by Shikha Jain on LinkedIn: "If you are attending ASCO this year,…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 12, 2024, 15:42 |
Insight
Sumanta Pal: Proud of this project on two levels
Sumanta Pal, Professor in the Department of Medical Oncology at City of Hope Medical Center,…
May 11, 2024, 00:51 |
Career
Joni Fausett: I joined Kite Pharma as the Head of US Medical Affairs
Joni Fausett, Head of US Medical Affairs at Kite Pharma, made the following post on…
May 9, 2024, 15:31 |
Blog
Hedyeh Ebrahimi: Unique challenges that community cancer centers face to engage in oncology clinical trials
Hedyeh Ebrahimi, Postdoctoral fellow at Genitourinary Cancer Research Team of City of Hope, shared a post…
May 7, 2024, 13:55 |
Blog
Karen Knudsen: Genentech reflects the depth and breadth of our commitments to improving the lives of cancer patients
Karen Knudsen shared a post by American Cancer Society on LinkedIn, adding: "Our work with…
Apr 23, 2024, 10:07 |
Insight
Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before
Ashley Magargee, Chief Executive Officer at Genentech, shared on LinkedIn: "We’re fortunate to have leading…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Apr 10, 2024, 08:53 |
Insight
Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers
Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…
Feb 23, 2024, 17:26 |
Blog
Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X: "Honored…
Dec 13, 2023, 11:08 |
Career
Genentech Welcomes Ashley Magargee as New CEO: A 20-Year Journey of Excellence and Leadership
Genentech shared today on LinkedIn: "We are excited to share that Ashley Magargee has been…
Dec 10, 2023, 17:54 |
Blog
Christian Rutzer: Roche and Novartis - Basel's Research and Innovation Powerhouses
Christian Rutzer, Deputy Head and Lead Scientist at the CIEB University of Basel, shared on…
Nov 23, 2023, 15:53 |
Blog
David Paragamian: Our Recently Diagnosed? Podcast is a Gold MarCom Award-winner
David Paragamian, Chief Executive Officer at Health Monitor Network, posted on LinkedIn: "Our Recently Diagnosed?…
Oct 12, 2023, 01:34 |
Opinion
Alexander Hardy: Today, we're commemorating a significant milestone at Genentech - the 25th anniversary of a groundbreaking medicine for patients with HER2+ metastatic breast cancer.
Aug 3, 2023, 19:36 |
Blog
I look forward to relocating back to the east coast to begin a new adventure in drug discovery and development - Mark McCarron
A professor and a venture capitalist walk into a bar…and the rest is history. I’ve…
All:
28
Posts:
1 - 100
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube